Ziwei Wang
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Rehabilitation top 10%
- Stroke Rehabilitation and Recovery
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 4
- Lung Cancer Research Studies 3
- Co-authors
- Deborah Korenstein (1 shared paper)Niloufer Khan (1 shared paper)Annie Yang (1 shared paper)Renee L. Gennarelli (1 shared paper)Lindsay Boyce (1 shared paper)Shrujal S. Baxi (1 shared paper)Mi Guo (1 shared paper)Xingtao Zhou (1 shared paper)
- Journals
- Frontiers in Oncology (3 papers)PLoS ONE (2 papers)International Journal of COPD (2 papers)OncoTargets and Therapy (2 papers)Food Hydrocolloids (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Ziwei Wang
38 papers receiving 753 citations
Ziwei Wang's Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 327
- Rehabilitation 34
- Immunology 95
- Geriatrics and Gerontology 12
- Pulmonary and Respiratory Medicine 89
Countries citing papers authored by Ziwei Wang
This map shows the geographic impact of Ziwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziwei Wang more than expected).
Fields of papers citing papers by Ziwei Wang
This network shows the impact of papers produced by Ziwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziwei Wang. The network helps show where Ziwei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ziwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis Hit paper breakdown → | 2018 | 442 |
| 2 | 2022 | 74 | |
| 3 | 2019 | 65 | |
| 4 | 2016 | 22 | |
| 5 | 2017 | 19 | |
| 6 | 2024 | 15 | |
| 7 | 2024 | 12 | |
| 8 | 2024 | 9 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 8 | |
| 11 | 2023 | 8 | |
| 12 | 2024 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 2021 | 7 | |
| 15 | 2024 | 7 | |
| 16 | 2024 | 5 | |
| 17 | 2023 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2024 | 3 |
About Ziwei Wang
Ziwei Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Computer Vision and Pattern Recognition, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 43 papers that have together received 761 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Research Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Advanced Control Systems Optimization (1 paper), Medical Image Segmentation Techniques (1 paper), Microencapsulation and Drying Processes (1 paper) and Human Pose and Action Recognition (1 paper). The work is most often cited by research in Oncology (327 citations), Rehabilitation (34 citations), Immunology (95 citations), Geriatrics and Gerontology (12 citations) and Pulmonary and Respiratory Medicine (89 citations). Ziwei Wang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Deborah Korenstein, Niloufer Khan, Annie Yang, Renee L. Gennarelli, Lindsay Boyce, Shrujal S. Baxi, Mi Guo, Xingtao Zhou, Qiang Wang and Yuyang Wang. Their work appears in journals such as Frontiers in Oncology, PLoS ONE, International Journal of COPD, OncoTargets and Therapy and Food Hydrocolloids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.